Deloitte UK | Audit, Tax, Consulting and Corporate Finance services from Deloitte

This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Global > United Kingdom > MORE

Global site selector

Records Per Page: Page 1/2

Pharmaceutical R&D internal rate of return falls for a second year but shows signs of stabilising

The R&D internal rate of return (IRR) of leading pharmaceutical companies has fallen for a second successive year to 7.2% in 2012 from 7.7% in 2011.

Deloitte appoints David Hodgson as new Healthcare and Life Sciences partner

Deloitte has announced the appointment of David Hodgson as a healthcare and life sciences partner within its Enterprise Risk Services practice.

Deloitte Centre for Health Solutions: Time is ripe to address the healthcare provision for the homeless

The Health and Social Care Act 2012 presents an opportunity to transform the way in which healthcare for the homeless is commissioned, according to a new report from the Deloitte Centre for Health Solutions.

Deloitte launches UK Centre for Health Solutions

New healthcare and life sciences research hub to encourage and support innovation in healthcare

Pharmaceutical R&D continues to perform, albeit against strengthening headwinds

All corporate functions have a role to play in ensuring R&D earns its investment, according to Deloitte and Thomson Reuters.

Evolution of partnering in drug development is leading to new business models for biotechnology

In the face of ongoing economic pressure and risk aversion, the evolution of partnering in drug development is leading to a reevaluated approach to biotechnology, according to Deloitte, the business advisory firm.

Pharmaceutical R&D is healthy but needs to be fitter, according to new analysis from Deloitte and Thomson Reuters

New analysis into the value generated by the research and development (R&D) carried out by leading pharmaceutical companies indicates that new approaches are needed if R&D is to be able to pay its way.

Deloitte life sciences & health care team celebrates corporate finance award success

The corporate finance life sciences & health care team at Deloitte, the business advisory firm, is celebrating after being named Corporate Financier of the Year at this year’s HealthInvestor Awards ceremony.

Improving quality of health care is a key factor in determining support for political candidates, says Deloitte survey

A survey indicates that 61% of UK adults see improving the quality of care provided by doctors and hospitals as highly important in determining their support for political candidates.

Deloitte announces new appointment to Life Sciences & Healthcare Practice

Deloitte, the business advisory firm, has appointed corporate finance specialist Chris Britten as a director to its expanding UK Life Sciences & Healthcare practice.

Page 1/2

Follow:

© 2013 Deloitte LLP. All rights reserved. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Please see About Deloitte for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its Member Firms. View our accessibility statement.

Get in touch

Audit

Consulting

Corporate Finance

Tax

Business and Professional Services

Charities and Not For Profit

Consumer Business

Energy & Resources

Financial Services

Government & Public Sector

Infrastructure & Capital Projects

Life Sciences

Manufacturing

Private Equity

Real Estate

Sports Business Group

Technology, Media & Telecommunications

Travel, Hospitality & Leisure

Cyber Security

Deloitte Analytics

Global Business Services

International Markets

Mergers & Acquisitions

Pensions Advisory

Private Equity

Private Markets

Sustainability Services

The Eurozone Crisis

Transforming the finance function

UK Futures

Audit publications

Deloitte Research UK

Economic commentary

International Tax and Business Guides

Chief Information Officer

CFO Programme

More